IL143297A0 - Nf-at mediates cardiac hypertrophy, methods and reagents related thereto - Google Patents

Nf-at mediates cardiac hypertrophy, methods and reagents related thereto

Info

Publication number
IL143297A0
IL143297A0 IL14329799A IL14329799A IL143297A0 IL 143297 A0 IL143297 A0 IL 143297A0 IL 14329799 A IL14329799 A IL 14329799A IL 14329799 A IL14329799 A IL 14329799A IL 143297 A0 IL143297 A0 IL 143297A0
Authority
IL
Israel
Prior art keywords
methods
cardiac hypertrophy
reagents related
mediates cardiac
mediates
Prior art date
Application number
IL14329799A
Other languages
English (en)
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of IL143297A0 publication Critical patent/IL143297A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8103—Exopeptidase (E.C. 3.4.11-19) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL14329799A 1998-11-24 1999-11-23 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto IL143297A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19897798A 1998-11-24 1998-11-24
PCT/US1999/027862 WO2000030671A2 (en) 1998-11-24 1999-11-23 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto

Publications (1)

Publication Number Publication Date
IL143297A0 true IL143297A0 (en) 2002-04-21

Family

ID=22735695

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14329799A IL143297A0 (en) 1998-11-24 1999-11-23 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto

Country Status (5)

Country Link
EP (1) EP1131086A2 (xx)
JP (1) JP2002530349A (xx)
CA (1) CA2352599A1 (xx)
IL (1) IL143297A0 (xx)
WO (1) WO2000030671A2 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6687428B2 (en) 2000-09-21 2004-02-03 Tera Op (Usa) Inc. Optical switch
US20130183686A1 (en) * 2008-11-11 2013-07-18 Donna Davidovich Method of evaluating immunosuppression

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993004203A1 (en) * 1991-08-22 1993-03-04 The Board Of Trustees Of The Leland Stanford Jr. University Screening methods for immunosuppressive agents
US6197925B1 (en) * 1991-08-22 2001-03-06 Sara Lee Corporation NF-AT polypeptides and polynucleotides
US5656452A (en) * 1993-01-15 1997-08-12 President And Fellows Of Harvard College NF-ATp, ' a T lymphocyte DNA-binding protein
WO1995005389A1 (en) * 1993-08-18 1995-02-23 The Board Of Trustees Of The Leland Stanford Junior University Sequence-specific glycoconjugate transcriptional antagonists
US5612455A (en) * 1994-07-05 1997-03-18 Tularik, Inc. Nuclear factors and binding assay
JP2001520170A (ja) * 1997-10-16 2001-10-30 ボード・オヴ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム Ｎｆ−ａｔ３機能に関連した心肥大動物モデルと治療法
WO1999040930A1 (en) * 1998-02-12 1999-08-19 Center For Blood Research, Inc. Specific inhibitors of nfat activation by calcineurin and their use in treating immune-related diseases

Also Published As

Publication number Publication date
WO2000030671A2 (en) 2000-06-02
WO2000030671A9 (en) 2001-05-17
WO2000030671A3 (en) 2000-11-09
EP1131086A2 (en) 2001-09-12
JP2002530349A (ja) 2002-09-17
CA2352599A1 (en) 2000-06-02

Similar Documents

Publication Publication Date Title
IL143529A0 (en) An electrolysis cell and methods utilizing the same
AU1329000A (en) Multidimensional uncertainty analysis
EP1156324A4 (en) PROCESS FOR THE DISTINCTION OF SAMPLES
EP1144092A4 (en) INTEGRATED PORTABLE BIOLOGICAL DETECTION SYSTEM
GB2349660B (en) Seabed analysis
HUP0103473A3 (en) Phosphoglycolipid and methods for its use
GB2342863B (en) Probe
EP0850402A4 (en) PRETREATMENT REAGENTS AND RELATED METHODS
GB0007933D0 (en) Assays,methods and means
GB2361101B (en) Data analysis
GB9803425D0 (en) Microtome
GB9707743D0 (en) Analysis
IL143297A0 (en) Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
GB9705744D0 (en) Methods for selecting cells and their uses
GB9807848D0 (en) Assay method and means
GB2348701B (en) Assays,methods and means
EP1120644A4 (en) CORROSION / ANTI-CORROSION ANALYSIS METHOD
GB9813778D0 (en) Assay methods and means
EP1071327A4 (en) SELF-ANTIGENED FRAGMENTS, METHODS AND ASSAYS
GB9810971D0 (en) Test rig
GB2339277B (en) A method of analysing the data from detector arrays in two or more modes
GB9827585D0 (en) Assay method
GB0120165D0 (en) Forensic and genealogical test
GB0026109D0 (en) An analysis method
GB2340940B (en) Sample collection